Related Experiment Video
Updated: Sep 6, 2025
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.0K
Tricuspid Valve Percutaneous Therapies.
Bhaskar Bhardwaj1, Joaquin E Cigarroa1, Firas Zahr2
1Division of Cardiology, Knight Cardiovascular Institute, OHSU, Portland, OR, United States.
Current Cardiology Reports
|June 29, 2022
Summary
Transcatheter tricuspid valve therapies are emerging for treating tricuspid regurgitation (TR). Current clinical trials show promising safety and effectiveness for these novel percutaneous interventions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Tricuspid regurgitation (TR) is a prevalent condition often underdiagnosed and undertreated.
- Traditional management of TR involves conservative medical therapy or surgical intervention, typically during left-sided valve surgery.
Purpose of the Study:
- To review current transcatheter tricuspid valve therapies.
- To discuss device selection for tricuspid regurgitation (TR) management.
- To explore the role of TR in other transcatheter valvular procedures.
Main Methods:
- Review of recently completed and ongoing clinical trials for percutaneous tricuspid valve therapies.
- Analysis of current literature on transcatheter device effectiveness and safety for TR.
Main Results:
- Emerging transcatheter devices for tricuspid repair and replacement are under investigation.
- Early clinical data suggest reassuring safety and effectiveness profiles for these percutaneous TR therapies.
Conclusions:
- Transcatheter approaches represent a growing option for managing tricuspid regurgitation.
- Further research and clinical trials are essential to establish the definitive role of these therapies.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
01:29Venous Thrombosis III: Interprofessional Care
21
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
21
01:22Heart Failure VI: Adjunct Therapies
26
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
26
01:25Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
01:17Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
01:21Cardiac Catheterization II: Right Heart Catheterization
156
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
156